Birdwatch Archive

Birdwatch Note

2021-12-24 01:13:00 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Remdesivir (Oct. 2020) and Regeneron (Nov. 2020) are both emergency use authorized (EUA) treatments by the FDA that were in use, and continue to be in use presently, before the first vaccine shots were administered. https://www.fda.gov/media/137566/download https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19

Written by 9795BF8962792425EFA8D2F4F92685B4
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1474098646383742979

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1474186313784086537
  • noteId - 1474186313784086537
  • participantId - 9795BF8962792425EFA8D2F4F92685B4
  • noteAuthorParticipantId -
  • createdAtMillis - 1640308380922
  • tweetId - 1474098646383742979
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable - BELIEVABLE_BY_MANY
  • harmful - CONSIDERABLE_HARM
  • validationDifficulty - EASY
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Remdesivir (Oct. 2020) and Regeneron (Nov. 2020) are both emergency use authorized (EUA) treatments by the FDA that were in use, and continue to be in use presently, before the first vaccine shots were administered. https://www.fda.gov/media/137566/download https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2021-12-24 01:13:00 UTC
(1640308380922)		 1969-12-31 23:59:59 UTC
(-1)		 1969-12-31 23:59:59 UTC
(-1)		 NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)		 47AD3BD4ED0E64C9EA74DB3A322FA6AA5E5F8D84E57A6E405CC624F53C571EC8
2021-12-24 01:13:00 UTC
(1640308380922)		 1969-12-31 23:59:59 UTC
(-1)		 1969-12-31 23:59:59 UTC
(-1)		 NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)		 9795BF8962792425EFA8D2F4F92685B4

Note Ratings

rated at rated by
2021-12-26 10:16:22 -0600 032C2482FB31D33B1FBDF91DF137CB8EE7E7001B48BC6896D8309B45C263253E Rating Details
2021-12-26 16:31:13 -0600 03990138F2DDCE4B568BB02B7DBB2875FA2FBBEFCC0C3E20DBDE660C723A6B6F Rating Details
2021-12-26 19:05:20 -0600 049BBA4526BD41F0F08920456B315618F8897EB981F51AAB37432E96E0E54DC6 Rating Details
2021-12-24 06:24:52 -0600 0F9D1457A0C8337275B4047BBA05D1711CD669C383D0C67862D4B91B080CDCEE Rating Details
2021-12-26 17:45:25 -0600 1D7DE7F77F6BE11FBEABB06029BACE931C1BA6CFB8EC126A17F77E4F4E6F1D99 Rating Details
2021-12-26 08:41:16 -0600 1FCB30EC85FC656606F9E9046325AC167B248CA3EEA50664C1058476259BC91B Rating Details
2021-12-25 21:41:53 -0600 25B4E94C643BDEA7BE5BD8C068FCD16EE8B6962D3F2F75BE47131095A3017CA1 Rating Details
2021-12-24 00:50:09 -0600 46D893DFC474111C12B5EF54ADED5291021E07B5BC4D944EB4F35D18A93785C7 Rating Details
2021-12-26 16:20:02 -0600 46FA80C35D762461268253940A3749CECEF7CC3898BB9C586C04B8FC7BDEB711 Rating Details
2021-12-25 02:31:37 -0600 495FF1E1B3FA1CE5D71C94B60635343CA237AAE157C9512239D5BAA6B14A9D70 Rating Details
2021-12-25 21:52:03 -0600 4EB3423EC4C9255DB34B81818BC1AB88972B8342132322E302FDAA83AEF384A6 Rating Details
2021-12-25 22:28:13 -0600 5A4A00EFAF0172896D574980B3B972D5DC5C6035D640E39335AEC6948B222E59 Rating Details
2021-12-23 21:57:29 -0600 5DF572C00219952302D69A62E7E2D4E3610F998F88CACECF4B5B51A51F44F541 Rating Details
2021-12-26 15:25:04 -0600 614247E9C25ECB767BD8A8E3C4153C2ED43118D195F5A6745B9AFACF50F13F79 Rating Details
2021-12-26 13:34:30 -0600 644FB79A15FE7632F8F0E6F892F7090B9CD86D1E70E0BEF74D8F8A9253A261B8 Rating Details
2021-12-26 14:06:25 -0600 682EC8F4F1BD2D252369DD19E6C22A4E72E880EB538DF72B28E193DED8D37E54 Rating Details
2021-12-25 21:22:05 -0600 6CD317D09D67F6123E4880DD9BBC73555377644948F45E9E2B2A529B4197D81E Rating Details
2021-12-26 08:54:20 -0600 8642BBB71C951CAA243E26566CBC2F70ECF312DDB13654DE02DD06B3EE3CC6AF Rating Details
2021-12-26 12:17:57 -0600 89485D4AEFE5506DCCE8A084B9C827134CB4FCFF2428C3D00C6E02B886531CEF Rating Details
2021-12-26 09:52:54 -0600 9EEAFF96D6774DBA31BC54E0A659D98B1911DFD377D4BE60261608410E8EE9C3 Rating Details
2021-12-25 21:33:10 -0600 A44876F035713EC16266C9B6E680FFE8FA23356D29801D08E043A05555D9E79E Rating Details
2021-12-26 16:46:15 -0600 B623C0190CA7CC9442C88B68E4EA894708D479826B5557F0F123EA89E9BFF2D1 Rating Details
2021-12-26 12:40:26 -0600 B78EFE723D7E7BCE39DC196B4E369E68F8F0139BBD78790A83BCE3FDD1531F2C Rating Details
2021-12-26 13:10:58 -0600 C11B9AA9D7DE38AD03B59B1EDFC0DAA7E5BBC800E0FB6D338558EC8C2027B447 Rating Details
2021-12-26 11:24:55 -0600 C951FC887E902B5E08B0E0303B69BB1FA3A188F898EC74C878455879A95F065A Rating Details
2021-12-26 09:41:03 -0600 CD3A63824D4CF6737A6EDEEDA86854C22882BE139DF1D1694EB0A215159529DE Rating Details
2021-12-25 22:03:29 -0600 DCE686AE1648030D7733B67F7890177C5D6F79B01C8747EFD5D384B9026A1F5B Rating Details
2021-12-26 23:50:16 -0600 DFB9366A66246A3E04FEAD8F0FA3EE08DCDF48FA6112CC532BEB55D8AF067055 Rating Details
2021-12-26 09:14:26 -0600 E17FC73872B1651586EDC69404AB2A7A0A15C64C7B8602E04AEFA59744505ABE Rating Details
2021-12-26 08:53:38 -0600 F1C16E14BE6FC187B1DDAB6F87F2BE98F539F8B5BDCA21C309F2D1BF189F21CB Rating Details
2021-12-27 00:06:54 -0600 F240EE3C9EA7306408DDAFE0A8538171E44068BBCF43847B35E5B6024F52A69B Rating Details
2021-12-24 00:50:09 -0600 Rating Details
2021-12-25 22:03:29 -0600 Rating Details
2021-12-26 17:45:25 -0600 Rating Details
2021-12-26 09:41:03 -0600 Rating Details
2021-12-26 08:53:38 -0600 Rating Details
2021-12-25 22:28:13 -0600 Rating Details
2021-12-26 23:50:16 -0600 Rating Details
2021-12-26 09:14:26 -0600 Rating Details
2021-12-26 13:34:30 -0600 Rating Details
2021-12-26 10:16:22 -0600 Rating Details
2021-12-26 08:54:20 -0600 Rating Details
2021-12-24 06:24:52 -0600 Rating Details
2021-12-26 12:17:57 -0600 Rating Details
2021-12-26 13:10:58 -0600 Rating Details
2021-12-26 09:52:54 -0600 Rating Details
2021-12-25 21:52:03 -0600 Rating Details
2021-12-25 21:41:53 -0600 Rating Details
2021-12-26 19:05:20 -0600 Rating Details
2021-12-26 16:31:13 -0600 Rating Details
2021-12-26 14:06:25 -0600 Rating Details
2021-12-26 08:41:16 -0600 Rating Details
2021-12-25 21:33:10 -0600 Rating Details
2021-12-26 16:20:02 -0600 Rating Details
2021-12-26 11:24:55 -0600 Rating Details
2021-12-25 02:31:37 -0600 Rating Details
2021-12-27 00:06:54 -0600 Rating Details
2021-12-26 15:25:04 -0600 Rating Details
2021-12-26 16:46:15 -0600 Rating Details
2021-12-23 21:57:29 -0600 Rating Details
2021-12-26 12:40:26 -0600 Rating Details
2021-12-25 21:22:05 -0600 Rating Details